earnings call
Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Madrigal Pharmaceuticals Inc (MDGL) SEC filings
Madrigal Pharmaceuticals Inc (MDGL) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported MDGL revenue for 2025-12-31 was $958.4M. Net income was -$288.3M. Revenue was up 432.1% from 2024-12-31 to 2025-12-31. MDGL currently screens at market cap $11.56B. The MDGL filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Madrigal Pharmaceuticals Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsearnings call
Event insights for MDGL — what management said, what changed, and why it matters.
Recent filings
MDGL SEC filings FAQ
What is the latest MDGL SEC filing?
The latest cached Madrigal Pharmaceuticals Inc (MDGL) filing on this page is 8-K · Aug 12, 2026. Filings: https://lician.com/sec/mdgl
What is the latest MDGL filing accession number?
The latest cached Madrigal Pharmaceuticals Inc (MDGL) accession number on this page is 0001628280-26-055962. Filing: https://lician.com/sec/mdgl/0001628280-26-055962
Which item codes are on the latest MDGL filing?
Cached item codes on the latest Madrigal Pharmaceuticals Inc (MDGL) 8-K are 5.02, 7.01, 9.01.
How many MDGL SEC filings are listed on this page?
This page lists 2 cached Madrigal Pharmaceuticals Inc (MDGL) SEC filings. Filings: https://lician.com/sec/mdgl
What events are listed on the MDGL SEC page?
Cached event headlines on this Madrigal Pharmaceuticals Inc (MDGL) SEC page: "MDGL earnings". Events: https://lician.com/sec/mdgl
What are MDGL's latest revenue and net income?
Latest cached Madrigal Pharmaceuticals Inc (MDGL) revenue for Dec 31, 2025 was $958.4M. Net income was -$288.3M. Statements: https://lician.com/financials/mdgl